| CD66a interactions between human melanoma and NK cells: a novel class I MHC-independent inhibitory mechanism of cytotoxicity G Markel, N Lieberman, G Katz, TI Arnon, M Lotem, O Drize, RS Blumberg, ... The Journal of Immunology 168 (6), 2803-2810, 2002 | 220 | 2002 |
| Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity A Machlenkin, O Goldberger, B Tirosh, A Paz, I Volovitz, E Bar-Haim, ... Clinical cancer research 11 (13), 4955-4961, 2005 | 136 | 2005 |
| Second neoplasms in patients with Merkel cell carcinoma B Brenner, A Sulkes, E Rakowsky, M Feinmesser, A Yukelson, ... Cancer 91 (7), 1358-1362, 2001 | 119 | 2001 |
| MHC class I‐restricted epitope spreading in the context of tumor rejection following vaccination with a single immunodominant CTL epitope K el‐Shami, B Tirosh, E Bar‐Haim, L Carmon, E Vadai, M Fridkin, ... European journal of immunology 29 (10), 3295-3301, 1999 | 111 | 1999 |
| Interrelationship between Dendritic Cell Trafficking and Francisella tularensis Dissemination following Airway Infection E Bar-Haim, O Gat, G Markel, H Cohen, A Shafferman, B Velan PLoS pathogens 4 (11), e1000211, 2008 | 91 | 2008 |
| Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy A Machlenkin, A Paz, E Bar Haim, O Goldberger, E Finkel, B Tirosh, ... Cancer research 65 (14), 6435-6442, 2005 | 80 | 2005 |
| Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles U Elia, S Ramishetti, R Rosenfeld, N Dammes, E Bar-Haim, GS Naidu, ... ACS nano 15 (6), 9627-9637, 2021 | 73 | 2021 |
| Toxins as biological weapons for terror—characteristics, challenges and medical countermeasures: a mini-review T Berger, A Eisenkraft, E Bar-Haim, M Kassirer, AA Aran, I Fogel Disaster and military medicine 2, 1-7, 2016 | 64 | 2016 |
| Yersinia pestis endowed with increased cytotoxicity is avirulent in a bubonic plague model and induces rapid protection against pneumonic plague A Zauberman, A Tidhar, Y Levy, E Bar-Haim, G Halperin, Y Flashner, ... PLoS One 4 (6), e5938, 2009 | 61 | 2009 |
| Discordance in the Effects of Yersinia pestis on the Dendritic Cell Functions Manifested by Induction of Maturation and Paralysis of Migration B Velan, E Bar-Haim, A Zauberman, E Mamroud, A Shafferman, S Cohen Infection and immunity 74 (11), 6365-6376, 2006 | 52 | 2006 |
| Increased lethality in influenza and SARS-CoV-2 coinfection is prevented by influenza immunity but not SARS-CoV-2 immunity H Achdout, EB Vitner, B Politi, S Melamed, Y Yahalom-Ronen, H Tamir, ... Nature Communications 12 (1), 5819, 2021 | 51 | 2021 |
| Characterization of novel breast carcinoma–associated BA46-derived peptides in HLA-A2.1/Db-β2mtransgenic mice L Carmon, I Bobilev-Priel, B Brenner, D Bobilev, A Paz, E Bar-Haim, ... The Journal of clinical investigation 110 (4), 453-462, 2002 | 50 | 2002 |
| Antitumor vaccination using peptide based vaccines L Eisenbach, E Bar-Haim, K El-Shami Immunology Letters 74 (1), 27-34, 2000 | 50 | 2000 |
| Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics A Nagler, S Kalaora, C Barbolin, A Gangaev, SLC Ketelaars, M Alon, ... Cell Reports 35 (13), 2021 | 49 | 2021 |
| The involvement of IL-17A in the murine response to sub-lethal inhalational infection with Francisella tularensis G Markel, E Bar-Haim, E Zahavy, H Cohen, O Cohen, A Shafferman, ... PloS one 5 (6), e11176, 2010 | 48 | 2010 |
| Early Immunogenicity and safety of the third dose of BNT162b2 mRNA Covid-19 vaccine among adults older than 60 years; real world experience M Gilboa, M Mandelboim, V Indenbaum, Y Lustig, C Cohen, G Rahav, ... J Infect Dis 5, 1-10, 2021 | 45* | 2021 |
| Identification of shared tumor-associated antigen peptides between two spontaneous lung carcinomas. O Mandelboim, E Bar-Haim, E Vadai, M Fridkin, L Eisenbach Journal of immunology (Baltimore, Md.: 1950) 159 (12), 6030-6036, 1997 | 38 | 1997 |
| Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus KM Morabito, TJ Ruckwardt, E Bar-Haim, D Nair, SM Moin, AJ Redwood, ... Frontiers in immunology 9, 1861, 2018 | 37 | 2018 |
| Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components I Mendelson, O Gat, R Aloni-Grinstein, Z Altboum, I Inbar, C Kronman, ... Vaccine 23 (48-49), 5688-5697, 2005 | 35 | 2005 |
| MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides E Bar-Haim, A Paz, A Machlenkin, D Hazzan, B Tirosh, L Carmon, ... British journal of cancer 91 (2), 398-407, 2004 | 34 | 2004 |
